Who owns QUALIGEN THERAPEUTICS INC?
- Ticker: QLGN
- CUSIP Number: 74754r202
Tip: Access positions for across all investors
Analyze quarterly positions in Qualigen Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Qualigen Therapeutics stock
Who bought or sold QUALIGEN THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Citadel Advisors | 154k | $26k | 100% | Sep 2024 |
|
| Hrt Financial | 98k | $16k | 59% | Sep 2024 |
|
| Geode Capital Management | 46k | $7.8k | 51% | Sep 2024 |
|
| BlackRock | 26k | $4.4k | 100% | Sep 2024 |
|
| BlackRock | 26k | $4.4k | 0% | Jun 2024 |
|
| Vanguard Group | 23k | $3.9k | 0% | Jun 2024 |
|
| Virtu Financial | 22k | $4.0k | -22% | Jun 2024 |
|
| Two Sigma Securities | 18k | $3.1k | 100% | Jun 2024 |
|
| Northern Trust | 12k | $2.0k | 0% | Sep 2024 |
|
| State Street Corporation | 11k | $1.9k | 0% | Jun 2024 |
|
| Jump Financial | 10k | $1.7k | 100% | Sep 2024 |
|
| HighMark Wealth Management | 8.0k | $1.4k | 0% | Sep 2024 |
|
| Tower Research Capital | 6.1k | $1.0k | 0% | Jun 2024 |
|
| Bank of America Corporation | 933.00 | $162.621900 | 1694% | Sep 2024 |
|
| Us Bancorp | 824.00 | $139.997600 | 0% | Sep 2024 |
|
| Group One Trading | 423.00 | $71.994600 | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 252.00 | $42.991200 | 0% | Sep 2024 |
|
| Signature | 20.00 | $3.000000 | 100% | Sep 2024 |
|
| Archer Investment Corp | 16.00 | $3.000000 | 0% | Sep 2024 |
|
| Royal Bank of Canada | 4.00 | $0 | 0% | Sep 2024 |
|
Who sold out of Qualigen Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Renaissance Technologies | Jun 2024 | 65k | $11k |
| XTX Topco | Jun 2024 | 23k | $4.0k |